Hollander David

Hollander David is listed in filings as Director at Kiora Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2025, including sale activity. Recent filings connect the profile to Kiora Pharmaceuticals, Inc. (KPRX) and Revance Therapeutics, Inc. - Common Stock (RVNC). The current snapshot covers public activity from Jul 3, 2024 to Apr 2, 2025. Reported amounts are shown as $58.6K to $16.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.